RFWA
EPZM

RPg Family Wealth Advisory’s Epizyme, Inc EPZM Stock Holding History

RPg Family Wealth Advisory’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$10.4K Hold
961
– – ﹤0.01% 284
2020
Q3 		$11.5K Hold
961
– – 0.01% 271
2020
Q2 		$15.4K Sell
961
-212
-18% -$3.7K 0.01% 236
2020
Q1 		$18.2K Buy
1,173
+233
+25% +$5K 0.01% 195
2019
Q4 		$23.1K Buy
+940
New +$14K 0.01% 199
2019
Q3 		– Sell
-855
Closed -$10.7K – 304
2019
Q2 		$10.7K Hold
855
– – 0.01% 273
2019
Q1 		$10.6K Buy
+855
New +$9.56K 0.01% 286

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

RPg Family Wealth Advisory's EPZM Position: Q4 2020 in Review

RPg Family Wealth Advisory held its Epizyme, Inc (EPZM) position steady in Q4 2020 at 961 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

RPg Family Wealth Advisory first reported a position in EPZM in Q1 2019 and has held it in 7 quarters since. The position peaked at $23.1K in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • RPg Family Wealth Advisory held 961 shares of Epizyme, Inc worth $10.4K as of Q4 2020.
  • RPg Family Wealth Advisory left its Epizyme, Inc share count unchanged in Q4 2020.
  • Epizyme, Inc made up ﹤0.01% of RPg Family Wealth Advisory's portfolio in Q4 2020, its #284 holding.
  • RPg Family Wealth Advisory first reported a position in Epizyme, Inc in Q1 2019 and has held it in 7 quarters since.
  • RPg Family Wealth Advisory's Epizyme, Inc position peaked at $23.1K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on RPg Family Wealth Advisory's 13F filing for Q4 2020, filed 16 Feb 2021.